Home
FLGT
FLGT News

Latest Fulgent Genetics Inc. (FLGT) News on April 3, 2025

Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?

Zacks

10 days ago

Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 03/06/2025

Argus Research

a month ago

HXL: Lowering target price to $16.00

MT Newswires

a month ago

UBS Adjusts Fulgent Genetics Price Target to $20 From $27, Maintains Neutral Rating

Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a month ago

Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

a month ago

Q4 2024 Fulgent Genetics Inc Earnings Call

Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates

Zacks

a month ago

Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire

a month ago

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Argus Research

a month ago

FLGT: Lowering target price to $17.00

Argus Research

a month ago

FLGT: Raising target price to $18.00

TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?

Zacks

2 months ago

TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Business Wire

2 months ago

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Argus Research

2 months ago

FLGT: Lowering target price to $17.00

Argus Research

2 months ago

FLGT: Lowering target price to $18.00

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Zacks

2 months ago

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Argus Research

2 months ago

HXL: Raising target price to $19.00

Argus Research

3 months ago

FLGT: Lowering target price to $18.00

Argus Research

3 months ago

FLGT: What does Argus have to say about FLGT?

With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing

Simply Wall St.

3 months ago

With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing

Argus Research

4 months ago

HXL: Lowering target price to $20.00

Argus Research

4 months ago

FLGT: What does Argus have to say about FLGT?

Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know

Zacks

4 months ago

Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know

Argus Research

4 months ago

FLGT: Raising target price to $21.00

Argus Research

4 months ago

FLGT: Raising target price to $19.00

All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy

Zacks

4 months ago

All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy

Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now

Insider Monkey

4 months ago

Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now

Argus Research

5 months ago

FLGT: Lowering target price to $20.00

Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth

Simply Wall St.

5 months ago

Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth

Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

5 months ago

Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations

Fulgent Genetics Reports Strong Q3 2024 Results

TipRanks

5 months ago

Fulgent Genetics Reports Strong Q3 2024 Results

Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline

GuruFocus.com

5 months ago

Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline

Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates

Zacks

5 months ago

Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates

Fulgent Reports Third Quarter 2024 Financial Results

Business Wire

5 months ago

Fulgent Reports Third Quarter 2024 Financial Results

TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates

Zacks

5 months ago

TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates

Argus Research

5 months ago

FLGT: Rating decreased to a HOLD

Fulgent to Participate in Upcoming Conferences

Business Wire

5 months ago

Fulgent to Participate in Upcoming Conferences

Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?

Zacks

5 months ago

Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Business Wire

5 months ago

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Business Wire

6 months ago

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Argus Research

6 months ago

FLGT: What does Argus have to say about FLGT?

Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?

Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107%

Simply Wall St.

7 months ago

Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107%

Argus Research

7 months ago

FLGT: Rating increased to a HOLD

Argus Research

7 months ago

FLGT: What does Argus have to say about FLGT?

Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

8 months ago

Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock?

How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22%

Zacks

8 months ago

How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22%

MT Newswires

8 months ago

Fulgent Genetics Swings to Q2 Earnings, Revenue Rises

Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates

Zacks

8 months ago

Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates

Fulgent Reports Second Quarter 2024 Financial Results

Business Wire

8 months ago

Fulgent Reports Second Quarter 2024 Financial Results

Argus Research

8 months ago

FLGT: Raising target price to $18.00

Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?

Zacks

9 months ago

Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?

Argus Research

9 months ago

HXL: Raising target price to $17.00

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

Business Wire

9 months ago

Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024

Argus Research

9 months ago

HXL: What does Argus have to say about FLGT?

With 50% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing

Simply Wall St.

9 months ago

With 50% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing

What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing?

Simply Wall St.

10 months ago

What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing?

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer

Business Wire

10 months ago

Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer

Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting

Business Wire

10 months ago

Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting

Moffitt and Fulgent Pharma partner on personalised cancer therapies

Pharmaceutical Technology

a year ago

Moffitt and Fulgent Pharma partner on personalised cancer therapies

Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics

Business Wire

a year ago

Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics

Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript

GuruFocus.com

a year ago

Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...

Thomson Reuters StreetEvents

a year ago

Q1 2024 Fulgent Genetics Inc Earnings Call

GuruFocus.com

a year ago

Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses

Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates

Fulgent Reports First Quarter 2024 Financial Results

Business Wire

a year ago

Fulgent Reports First Quarter 2024 Financial Results

Argus Research

a year ago

FLGT: What does Argus have to say about FLGT?

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

Business Wire

a year ago

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years

Simply Wall St.

a year ago

Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years

An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued

Fulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Fulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q4 2023 Fulgent Genetics Inc Earnings Call

Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023

GuruFocus.com

a year ago

Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

a year ago

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

Business Wire

a year ago

Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

PR Newswire

a year ago

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

Hope Bancorp, Inc. (NASDAQ:HOPE) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Hope Bancorp, Inc. (NASDAQ:HOPE) Q4 2023 Earnings Call Transcript

Associated Press Finance

a year ago

Cimpress: Fiscal Q2 Earnings Snapshot

Navitas Semiconductor Corporation's (NASDAQ:NVTS) institutional investors lost 6.1% over the past week but have profited from longer-term gains

Simply Wall St.

a year ago

Navitas Semiconductor Corporation's (NASDAQ:NVTS) institutional investors lost 6.1% over the past week but have profited from longer-term gains

MAG Silver (MAG) Reports Solid Production at Juanicipio

Zacks

a year ago

MAG Silver (MAG) Reports Solid Production at Juanicipio

Should You Think About Buying Lumen Technologies, Inc. (NYSE:LUMN) Now?

Simply Wall St.

a year ago

Should You Think About Buying Lumen Technologies, Inc. (NYSE:LUMN) Now?

Gentherm Announces Date for 2023 Fourth Quarter and Year-End Results News Release and Conference Call

GlobeNewswire

a year ago

Gentherm Announces Date for 2023 Fourth Quarter and Year-End Results News Release and Conference Call

GuruFocus.com

a year ago

TriCo Bancshares (TCBK) Reports Decline in Q4 Net Income Amidst Economic Headwinds

Associated Press Finance

a year ago

TriCo: Q4 Earnings Snapshot

TriCo Bancshares Announces Fourth Quarter 2023 Results

Business Wire

a year ago

TriCo Bancshares Announces Fourth Quarter 2023 Results

What Is Energy Recovery, Inc.'s (NASDAQ:ERII) Share Price Doing?

Simply Wall St.

a year ago

What Is Energy Recovery, Inc.'s (NASDAQ:ERII) Share Price Doing?

Keros Therapeutics, Inc. (KROS) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

a year ago

Keros Therapeutics, Inc. (KROS) Is a Great Choice for 'Trend' Investors, Here's Why

Ryan Specialty and ICBC Sign Lease Deals at 1185 Avenue of the Americas

Commercial Observer

a year ago

Ryan Specialty and ICBC Sign Lease Deals at 1185 Avenue of the Americas

Lexin Capital Buys Back Its Defaulted Chelsea Office Loan at a Discount

Commercial Observer

a year ago

Lexin Capital Buys Back Its Defaulted Chelsea Office Loan at a Discount

1 Hydrogen Stock to Buy Hand Over Fist and 2 to Avoid

Motley Fool

a year ago

1 Hydrogen Stock to Buy Hand Over Fist and 2 to Avoid

Why Hertz Global Stock Popped Today

Motley Fool

a year ago

Why Hertz Global Stock Popped Today

UMH PROPERTIES, INC. WILL HOST FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL

GlobeNewswire

a year ago

UMH PROPERTIES, INC. WILL HOST FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL

3 Growth Stocks That Could Go Parabolic in 2024

Motley Fool

a year ago

3 Growth Stocks That Could Go Parabolic in 2024

Institutional investors are The Vita Coco Company, Inc.'s (NASDAQ:COCO) biggest bettors and were rewarded after last week's US$70m market cap gain

Simply Wall St.

a year ago

Institutional investors are The Vita Coco Company, Inc.'s (NASDAQ:COCO) biggest bettors and were rewarded after last week's US$70m market cap gain

It Might Not Be A Great Idea To Buy Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) For Its Next Dividend

Morgan Stanley Banker Lifted Hedge Fund From 'Kiddie Table' With Stock Tips

Bloomberg

a year ago

Morgan Stanley Banker Lifted Hedge Fund From 'Kiddie Table' With Stock Tips

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Home Furnishing and Improvement Retail Stocks Q3 In Review: Floor And Decor (NYSE:FND) Vs Peers

StockStory

a year ago

Home Furnishing and Improvement Retail Stocks Q3 In Review: Floor And Decor (NYSE:FND) Vs Peers

Share on Social Networks: